[1]
|
Rosenberg, I.H. (1997) Sarcopenia: Origins and Clinical Relevance. The Journal of Nutrition, 127, 990S-991S.
https://doi.org/10.1093/jn/127.5.990S
|
[2]
|
Yang, L., Yao, X., Shen, J., et al. (2020) Comparison of Revised EWGSOP Criteria and Four Other Diagnostic Criteria of Sarcopenia in Chinese Community-Dwelling Elderly Residents. Experimental Gerontology, 130, Article No. 110798.
https://doi.org/10.1016/j.exger.2019.110798
|
[3]
|
Anker, S.D., Morley, J.E. and von Haehling, S. (2016) Welcome to the ICD-10 Code for Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle, 7, 512-514. https://doi.org/10.1002/jcsm.12147
|
[4]
|
Cruz-Jentoft, A.J., Bahat, G., Bauer, J., et al. (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing, 48, 16-31. https://doi.org/10.1093/ageing/afy169
|
[5]
|
Sousa, A.S., Guerra, R.S., Fonseca, I., Pichel, F. and Amaral, T.F. (2015) Sarcopenia among Hospitalized Patients—A Cross-Sectional Study. Clinical Nutrition, 34, 1239-1244. https://doi.org/10.1016/j.clnu.2014.12.015
|
[6]
|
Ligthart-Melis, G.C., Luiking, Y.C., Kakourou, A., et al. (2020) Frailty, Sarcopenia, and Malnutrition Frequently (Co-)Occur in Hospitalized Older Adults: A Systematic Review and Meta-analysis. Journal of the American Medical Directors Association, 21, 1216-1228. https://doi.org/10.1016/j.jamda.2020.03.006
|
[7]
|
姜珊, 康琳, 刘晓红. 2019亚洲肌少症诊断及治疗共识解读[J]. 中华老年医学杂志, 2020, 39(4): 373-374.
|
[8]
|
Chen, L.K., Woo, J., Assantachai, P., et al. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21, 300-307.
https://doi.org/10.1016/j.jamda.2019.12.012
|
[9]
|
Kashani, K.B., Frazee, E.N., Kukrálová, L., et al. (2017) Evalu-ating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index. Critical Care Medicine, 45, e23-e29.
https://doi.org/10.1097/CCM.0000000000002013
|
[10]
|
Kashani, K., Rosner, M.H. and Ostermann, M. (2020) Creatinine: From Physiology to Clinical Application. European Journal of Internal Medicine, 72, 9-14. https://doi.org/10.1016/j.ejim.2019.10.025
|
[11]
|
Ravn, B., Rimes-Stigare, C., Bell, M., et al. (2019) Creatinine versus Cystatin C Based Glomerular Filtration Rate in Critically Ill Patients. Journal of Critical Care, 52, 136-140. https://doi.org/10.1016/j.jcrc.2019.04.007
|
[12]
|
Suzuki, K., Furuse, H., Tsuda, T., et al. (2015) Utility of Creatinine/Cystatin C ratio as a Predictive Marker for Adverse Effects of Chemotherapy in Lung Cancer: A Retrospective Study. Journal of International Medical Research, 43, 573-582. https://doi.org/10.1177/0300060515579116
|
[13]
|
Amado, C.A., García-Unzueta, M.T., Lavin, B.A., et al. (2019) The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients. Respiration, 97, 302-309. https://doi.org/10.1159/000494296
|
[14]
|
López-Campos, J.L., Soler-Cataluña, J.J. and Miravitlles, M. (2020) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges. Archivos de Bronconeumología (English Edition), 56, 65-67. https://doi.org/10.1016/j.arbr.2019.06.014
|
[15]
|
Hirai, K., Tanaka, A., Homma, T., et al. (2021) Serum Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease. Clinical Nutrition, 40, 1274-1280.
https://doi.org/10.1016/j.clnu.2020.08.010
|
[16]
|
Barreto, E.F., Kanderi, T., DiCecco, S.R., et al. (2019) Sarcopenia Index Is a Simple Objective Screening Tool for Malnutrition in the Critically Ill. Journal of Parenteral and Enteral Nutrition, 43, 780-788.
https://doi.org/10.1002/jpen.1492
|
[17]
|
Warnken-Miralles, M.D., López-García, F., Zamora-Molina, L., et al. (2021) Sarcopenia Index in Hospitalized Patients with Chronic Obstructive Pulmonary Disease Exacerbation. Medicina (B Aires), 81, 323-328. (In Spanish)
|
[18]
|
Wu, Y.K., Li, M., Zhang, Y.C., et al. (2022) The Sarcopenia Index Is an Effective Predictor for Malnutrition in Patients with Liver Cirrhosis. Nutrition & Dietetics, 79, 563-571. https://doi.org/10.1111/1747-0080.12738
|
[19]
|
Lu, Y.-W., Tsai, Y.-L., Chou, R.-H., et al. (2021) Serum Creatinine to Cystatin C Ratio Is Associated with Major Adverse Cardiovascular Events in Patients with Obstructive Coronary Artery Disease. Nutrition, Metabolism and Cardiovascular Diseases, 31, 1509-1515. https://doi.org/10.1016/j.numecd.2021.01.024
|
[20]
|
Chen, Z., Zha, L., Ma, X., et al. (2022) Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung, 200, 609-617.
https://doi.org/10.1007/s00408-022-00568-5
|
[21]
|
He, Q., Jiang, J., Xie, L., Zhang, L. and Yang, M. (2018) A Sarcopenia Index Based on Serum Creatinine and Cystatin C Cannot Accurately Detect either Low Muscle Mass or Sarcopenia in Urban Community-Dwelling Older People. Scientific Reports, 8, Article No. 11534. https://doi.org/10.1038/s41598-018-29808-6
|